GO
Loading...

GlaxoSmithKline PLC

More

  • Earnings set to drive markets again Wednesday, 22 Oct 2014 | 5:55 AM ET
    Traders on the floor of the New York Stock Exchange.

    Earnings news will take center stage Wednesday after another day of strong stock market gains cemented the view that the worst is over.

  • LONDON, Oct 22- Johnson& Johnson is accelerating work on its experimental Ebola vaccine and said on Wednesday that it aims to have 1 million doses ready in 2015, of which 250,000 are expected to be available by May. There is currently no proven vaccine against the deadly disease but several companies are racing to develop products and clinical tests on two- from...

  • Earnings set to take markets' center stage Tuesday, 21 Oct 2014 | 7:29 PM ET
    Traders on the floor of the New York Stock Exchange.

    Earnings news will take center stage Wednesday after another day of strong stock market gains cemented the view that the worst is over.

  • Ebola vaccine could be ready in 3 months: CEO Tuesday, 21 Oct 2014 | 6:45 PM ET
    A CDC safety training course on Ebola in Anniston, Ala.

    A new Ebola vaccine could be ready to send to West Africa soon, NewLink Genetics' Charles Link says.

  • WHO: Ebola vaccine trials in W. Africa in January Tuesday, 21 Oct 2014 | 7:19 AM ET

    GENEVA— Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe, a top World Health Organization official said Tuesday. The Ebola outbreak in West Africa has already killed over 4,500 people, mostly in Liberia, Guinea and Sierra Leone, since it emerged 10...

  • Ship bound TX hospital worker negative for Ebola Sunday, 19 Oct 2014 | 9:56 AM ET
    In this handout from the Center for Disease Control, a colorized transmission electron micrograph (TEM) of a Ebola virus virion is seen.

    A Dallas hospital lab worker in isolation on a cruse after possible exposure to Ebola has tested negative for the disease.

  • US asks labs to plan to produce Ebola drug Zmapp Friday, 17 Oct 2014 | 2:32 PM ET
    In this handout from the Center for Disease Control, a colorized transmission electron micrograph (TEM) of a Ebola virus virion is seen.

    U.S. officials have asked three advanced biology laboratories to submit plans for producing the experimental Ebola drug ZMapp.

  • No Ebola epidemic in US without 'mutation:' CDC Thursday, 16 Oct 2014 | 5:25 PM ET
    A man dressed in protective hazmat clothing treats the sidewalk in front of an apartment where a second person diagnosed with the Ebola virus resides on October 12, in Dallas, Texas

    A top health official said an Ebola epidemic in the U.S. won't happen unless the virus mutates.

  • Ebola: Will we handle the next outbreak better? Wednesday, 15 Oct 2014 | 10:00 AM ET
    Italian Air Force soldiers attend a military exercise preparing to help people infected with the Ebola virus at the Pratica di Mare Air Base, near Rome, on September 24, 2014.

    The Ebola outbreak rages on. But there is no vaccine for this deadly disease, raising questions if the world is prepared for an epidemic.

  • LONDON, Oct 14- GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process. Britain's biggest drug maker is looking to divest the mature products in a bid to improve its growth profile and wants to dispose of...

  • CDC must 'rethink' its approach to Ebola: Official Monday, 13 Oct 2014 | 1:26 PM ET
    A man dressed in protective hazmat clothing treats the sidewalk in front of an apartment where a second person diagnosed with the Ebola virus resides on October 12, in Dallas, Texas

    "We have to rethink the way we address Ebola infection control because even a single infection is unacceptable," said Dr. Thomas Frieden.

  • Cramer: Activists are picking on the wrong chiefs Thursday, 9 Oct 2014 | 6:25 PM ET
    Jim Cramer on Mad Money.

    Jim Cramer takes on activist calls to CEOs strong performing companies, and suggests they realign their attention

  • 'Ebola.com' can be yours for $150,000 Thursday, 9 Oct 2014 | 9:53 AM ET
    The Cleaning Guys hazmat cleanup company are seen here as they sanitize the apartment where Ebola patient Thomas Eric Duncan was staying before being admitted to a hospital in Dallas.

    It's not unusual for big pharmaceutical companies to hold domains for major diseases on the Internet. But who would want to own Ebola.com?

  • Why we haven't cured Ebola yet Wednesday, 8 Oct 2014 | 2:41 PM ET
    U.S. Navy microbiologist Lt. Jimmy Regeimbal prepares to test blood samples for Ebola at the U.S. Navy mobile laboratory on Oct. 5, 2014 near Gbarnga, Liberia.

    Several drug companies are moving to test vaccines and drug treatments for Ebola, but their full effect might not be felt until the next outbreak.

  • Early movers: JCP, COST, CMI, GRUB, KRFT, YUM Wednesday, 8 Oct 2014 | 7:48 AM ET
    Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • GSK investigating corruption allegations in UAE Wednesday, 8 Oct 2014 | 1:17 AM ET

    GlaxoSmithKline, which was slapped with a record fine for corruption in China, said it was looking into allegations of corruption in UAE.

  • Fast-tracking an Ebola vaccine may prove too slow Tuesday, 7 Oct 2014 | 12:16 PM ET
    Ebola virus

    GlaxoSmithKline said it's speeding up trials and scaling production of an Ebola vaccine, but does not expect to be able to make it in mass quantities for 12 to 18 months.

  • While Lilly's shares hardly budged on the news, the ADRs of Israel- based XTL Biopharmaceuticals Inc, which is developing its own lupus treatment, nearly tripled to $5.00. About 1.5 million people in the United States are estimated to suffer from lupus, according to the U.S. Centers of Disease Control and Prevention. The U.S. Food and Drug Administration approved...

  • Ebola vaccine: Why it's taking so long to make one Thursday, 2 Oct 2014 | 10:46 AM ET
    A health worker helps a doctor to fix his protective suit, on October 1, 2014 at MSF's (Doctors Without Borders) Ebola treatment center in Monrovia. Liberia.

    Efforts to develop an Ebola vaccine have been in the works for some time. But experts say it's unlikely to see one available anytime soon.

  • NEW YORK, Oct. 1- Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.